Form 4: Cosmos Health CFO Acquires Shares in Debt Exchange

Sentiment:

Insider Transaction Filing


Cosmos Health Inc. reports that Chief Financial Officer Georgios Terzis acquired 168,135 shares of common stock through a debt exchange, valued at $0.2498 per share.

Summary

  • Georgios Terzis, Chief Financial Officer of Cosmos Health Inc., acquired 168,135 shares of common stock.
  • The acquisition occurred on June 16, 2026, through a debt exchange agreement.
  • The shares were acquired at a price of $0.2498 per share, totaling $42,000.
  • This transaction was in exchange for settling outstanding debt owed by the company to Mr. Terzis.
  • Following the transaction, Mr. Terzis beneficially owns 2,235,398 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While it resolves company debt and shows executive commitment, it's a standard financial maneuver rather than a growth indicator.

Positives

  • The company successfully settled $42,000 of debt owed to its CFO.
  • The CFO's acquisition of shares at a fair market value indicates confidence in the company's stock.
  • The transaction strengthens the company's balance sheet by reducing debt.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which solely reports a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that insider transactions, particularly debt-for-equity swaps, are common in the biotechnology and healthcare sectors as companies manage their capital structures and incentivize key executives.

Related Party Transactions

  • Georgios Terzis, the company's CFO, engaged in a debt exchange with Cosmos Health Inc. to acquire company shares.

Stakeholder Impact

  • Shareholders: The transaction reduces company debt, which can be viewed positively. The acquisition by the CFO at fair market value may signal confidence, but the direct impact on share price is minimal without further context.
  • Creditors: The settlement of debt owed to the CFO reduces the company's liabilities.
  • Employees: No direct impact is indicated.

Key Dates

DateDescription
06/16/2026Transaction Date and Deemed Execution Date for the debt exchange and acquisition of shares.
06/17/2026Signature date on the Form 4 filing.

Keywords

Cosmos Health Inc., COSM, Form 4, Insider Transaction, Debt Exchange, Chief Financial Officer, Georgios Terzis, Common Stock, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.